SIS
KRYS icon

Sound Income Strategies’s Krystal Biotech KRYS Stock Holding History

Sound Income Strategies’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-137
Closed -$35.5K – 1524
2026
Q1 		$35.5K Hold
137
– – ﹤0.01% 948
2025
Q4 		$39K Buy
137
+127
+1,270% +$26.7K ﹤0.01% 890
2025
Q3 		$1.89K Hold
10
– – ﹤0.01% 1353
2025
Q2 		$1.38K Hold
10
– – ﹤0.01% 1320
2025
Q1 		$1.8K Hold
10
– – ﹤0.01% 1255
2024
Q4 		$1.57K Hold
10
– – ﹤0.01% 1210
2024
Q3 		$1.82K Buy
+10
New +$1.93K ﹤0.01% 1145

Other funds holding KRYS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sound Income Strategies's KRYS Position: Q2 2026 in Review

Sound Income Strategies sold out of Krystal Biotech (KRYS) in Q2 2026, closing a stake of 137 shares — an estimated $35.5K sold.

Sound Income Strategies first reported a position in KRYS in Q3 2024 and held it in 7 quarters. The position peaked at $39K in Q4 2025. 310 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Sound Income Strategies reported no remaining Krystal Biotech position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 137 Krystal Biotech shares in Q2 2026, an estimated $35.5K.
  • Sound Income Strategies first reported a position in Krystal Biotech in Q3 2024 and held it in 7 quarters.
  • Sound Income Strategies's Krystal Biotech position peaked at $39K in Q4 2025.
  • 310 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.